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α-Synuclein is a presynaptic protein that regulates synaptic vesicle (SV) trafficking.
In Parkinson’s disease (PD) and several other neurodegenerative disorders, aberrant
oligomerization and aggregation of α-synuclein lead to synaptic dysfunction and
neurotoxicity. Despite evidence that α-synuclein oligomers are generated within neurons
under physiological conditions, and that altering the balance of monomers and
oligomers contributes to disease pathogenesis, how each molecular species of
α-synuclein impacts SV trafficking is currently unknown. To address this, we have
taken advantage of lamprey giant reticulospinal (RS) synapses, which are accessible
to acute perturbations via axonal microinjection of recombinant proteins. We previously
reported that acute introduction of monomeric α-synuclein inhibited SV recycling,
including effects on the clathrin pathway. Here, we report the effects of α-synuclein
dimers at synapses. Similar to monomeric α-synuclein, both recombinant α-synuclein
dimers that were evaluated bound to small liposomes containing anionic lipids in vitro,
but with reduced efficacy. When introduced to synapses, the α-synuclein dimers
also induced SV recycling defects, which included a build up of clathrin-coated pits
(CCPs) with constricted necks that were still attached to the plasma membrane, a
phenotype indicative of a vesicle fission defect. Interestingly, both α-synuclein dimers
induced longer necks on CCPs as well as complex, branching membrane tubules,
which were distinct from the CCPs induced by a dynamin inhibitor, Dynasore. In
contrast, monomeric α-synuclein induced a buildup of free clathrin-coated vesicles
(CCVs), indicating an inhibition of clathrin-mediated endocytosis at a later stage
during the clathrin uncoating process. Taken together, these data further support the
conclusion that excess α-synuclein impairs SV recycling. The data additionally reveal
that monomeric and dimeric α-synuclein produce distinct effects on clathrin-mediated
endocytosis, predicting different molecular mechanisms. Understanding what these
mechanisms are could help to further elucidate the normal functions of this protein,
as well as the mechanisms underlying PD pathologies.
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INTRODUCTION
α-Synuclein is a small (140 amino acid) presynaptic protein
that interacts with synaptic vesicles (SVs) and regulates SV
trafficking (Maroteaux et al., 1988; Murphy et al., 2000; Greten-
Harrison et al., 2010; Vargas et al., 2014; Logan et al., 2017).
Although its physiological function is still under investigation,
overexpression or mutation of the α-synuclein gene, which lead
to misfolding and aggregation of the protein, are linked to
familial Parkinson’s disease (PD; Krüger et al., 1998; Spillantini
et al., 1998; Lee and Trojanowski, 2006; Bendor et al., 2013;
Dettmer et al., 2016; Lautenschläger et al., 2017). α-Synuclein
overexpression and aggregation are also commonly observed
in other neurodegenerative disorders, including Lewy body
dementia (LBD), multiple systems atrophy and some variants
of Alzheimer’s disease (Schulz-Schaeffer, 2010; Moussaud et al.,
2014; Ingelsson, 2016). In animal models, overexpression
of α-synuclein induces aberrant aggregation of the protein
throughout neurons, causing numerous cellular defects including
synaptic and mitochondrial impairment, which ultimately lead
to neurodegeneration (Surguchov, 2008; Dawson et al., 2010;
Scott et al., 2010; Nakamura et al., 2011; Nakamura, 2013;
Lautenschläger et al., 2017).
In addition to somatic aggregation and Lewy body formation,
pathophysiological accumulation of α-synuclein occurs in
presynaptic nerve terminals, leading to synaptic defects (Schulz-
Schaeffer, 2010; Scott et al., 2010; Unni et al., 2010; Spinelli
et al., 2014). In LBD, the vast majority of aggregated α-synuclein
localizes to synapses throughout the frontal cortex, while only
a small fraction of aggregated α-synuclein is in the somatic
Lewy bodies (Kramer and Schulz-Schaeffer, 2007; Schulz-
Schaeffer, 2010). This synaptic aggregation correlates with
greater cognitive deficits (Poletti et al., 2011; Irwin et al., 2013).
In cultured mammalian neurons, overexpression of α-synuclein
or exogenous application leads to measurable oligomerization
and aggregation at presynapses (Scott et al., 2010; Volpicelli-
Daley et al., 2011; Boassa et al., 2013; Spinelli et al., 2014).
Similarly, a PD mouse model also exhibited significant synaptic
aggregation of α-synuclein (Spinelli et al., 2014). α-Synuclein
overexpression depletes synapses of several major presynaptic
proteins, including synapsin (Nemani et al., 2010; Scott et al.,
2010; Spinelli et al., 2014), an effect that has also been observed
post mortem in LBD brains (Scott et al., 2010). A growing body
of evidence indicates that excess α-synuclein, delivered acutely
or by overexpression, inhibits neurotransmission primarily by
impairing SV recycling and/or reclustering after endocytosis
(Nemani et al., 2010; Scott et al., 2010; Busch et al., 2014; Xu et al.,
2016; Eguchi et al., 2017), though effects on fusion pore kinetics
during exocytosis were also recently reported (Logan et al., 2017).
While it is clear that increased levels of α-synuclein impair
SV trafficking, the underlying mechanisms remain unknown,
though excess microtubule polymerization may play a role
(Eguchi et al., 2017).
The classic model for α-synuclein toxicity postulates
that aberrant folding of monomeric α-synuclein, or its
overexpression, leads to formation of small toxic oligomers,
aggregates and fibrils, resulting in deleterious effects throughout
the neuron (Lee and Trojanowski, 2006). However, there is an
ongoing debate about whether the native form of α-synuclein
is monomeric or tetrameric, which brings this linear model
into question (Bartels et al., 2011; Wang et al., 2011; Burré
et al., 2013, 2015; Dettmer et al., 2015b). While it is generally
agreed that neurons generate some α-synuclein oligomers
under physiological conditions (Wang et al., 2014), and that
altering the balance of monomers and oligomers contributes to
disease pathogenesis, how each molecular species of α-synuclein
(e.g., monomer, dimer, tetramer, etc.) impacts vesicle trafficking
is unknown because oligomerization status is difficult to control
in most overexpression models. In contrast, acute perturbations
at large vertebrate synapses offer an amenable approach to
this problem. Lamprey reticulospinal (RS) synapses are large,
glutamatergic synapses that reside within the giant axons of
the lamprey spinal cord, and they have been instrumental
in elucidating the molecular mechanisms of SV trafficking
(Pieribone et al., 1995; Shupliakov et al., 1997; Gad et al., 2000;
Bloom et al., 2003; Brodin and Shupliakov, 2006). Using this
preparation, we previously demonstrated that acute introduction
of monomeric α-synuclein directly to presynapses severely
inhibited SV endocytosis (Busch et al., 2014). The results were
consistent with effects on both clathrin-mediated endocytosis,
as well as bulk endocytosis (Busch et al., 2014). Similarly,
acute dialysis of monomeric α-synuclein to the mammalian
calyx of Held impaired vesicle endocytosis, whereas exocytosis
was relatively unaffected (Xu et al., 2016; Eguchi et al., 2017).
However, whether increasing other molecular species of
α-synuclein affects SV trafficking, and how, is completely
unknown.
The goal of this study was to determine how α-synuclein
dimers affect SV trafficking. Do α-synuclein dimers produce
any effects on SV trafficking? If so, do these effects parallel
those caused by monomeric α-synuclein, or are they unique
and distinct? Alternatively, are synapses able to tolerate high
levels of α-synuclein dimers, unlike monomeric α-synuclein?
Our experiments utilized two recombinant α-synuclein dimers
(CC and NC dimers), which were previously reported to
exhibit similar folding, aggregation and fibrillation properties
to monomeric α-synuclein (Pivato et al., 2012). α-Synuclein
CC dimer comprises two α-synuclein molecules covalently
linked at their C-termini, while NC dimer brings together the
N-terminus of one α-synuclein with the C-terminus of another,
thus likely producing parallel and anti-parallel dimers that were
implicated as physiologic forms in a recent study on endogenous
α-synuclein multimers (Wang et al., 2014). Here, using lamprey
synapses, we demonstrate that both α-synuclein dimers inhibited
SV recycling from the plasma membrane, similar to previous
observations with monomeric α-synuclein (Busch et al., 2014).
However, unlike monomeric α-synuclein, which inhibits the
uncoating of CCVs, the α-synuclein dimers selectively inhibited
clathrin-mediated SV recycling at an earlier stage during the
vesicle fission step. These effects were also distinct from those
produced by an inhibitor of dynamin, the GTPase that drives
vesicle scission from the PM. Taken together, these data further
corroborate the finding that excess α-synuclein impairs SV
endocytosis and illustrate a novel concept that α-synuclein
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monomers and dimers affect different steps in the endocytic
pathway.
MATERIALS AND METHODS
Recombinant Proteins and SDS-PAGE
Wild type human α-synuclein (a.a. 1–140) was bacterially
expressed in E. coli BL21 (DE3) from a pET28b plasmid
(Novagen), as previously described (Figure 1A; Pivato et al.,
2012). CC dimer was produced by adding terminal GC residues
after a.a. 140 of the α-synuclein sequence, which allowed the
molecules to be covalently linked by disulfide bonds at their
C-termini (Figure 1B). NC dimer was produced by including
two full-length copies of α-synuclein in the same plasmid, thus
generating a dimer as a single polypeptide (Figure 1B). After
expression and purification, α-synuclein dimers were isolated
from monomers using anionic exchange and then lyophilized
for long-term storage. Prior to use, the lyophilized dimers were
resuspended in lamprey internal solution (180 mM KCl, 10 mM
HEPES K+, pH 7.4). Any unwanted higher molecular weight
α-synuclein oligomers or aggregates that may have formed
during the lyophilization process were removed by passing
the protein sample through a Microconr YM-100 centrifugal
filter. Prior to injection, all preparations of monomeric and
dimeric α-synuclein were run on a 12% SDS-PAGE gel and
Coommassie stained in order to confirm purity and molecular
weights (Figure 1C).
Liposome Binding and Western Blotting
Liposomes were generated using 16:0–18:1 phosphatidylcholine
(PC), or alternatively 16:0–18:1 1-phosphatidic acid (PA)
and PC in a 1:1 ratio (Avanti Polar Lipids, Alabaster, AL,
USA). The PC component of all liposomes included 1%
fluorescently tagged 18:1–12:0 nitrobenzoxadiazole-PC (NBD-
PC). Liposomes were prepared as previously described (Busch
et al., 2014). Briefly, 1 mg of total lipids was added to 200
µl of 2:1 chloroform:methanol and dried over a stream of
nitrogen. The membranes were swollen in 300 mM sucrose
at 37◦C for 20 min and then vortexed, thus forming large,
heterogeneous liposomes. Liposomes were sonicated in order to
generate small, uniform liposomes (∼30 nm diameter) and then
ultracentrifuged at 80,000× g for 20 min at 25◦C to remove
any large liposomes by sedimentation. Liposome binding was
performed as previously described (Burré et al., 2012; Busch et al.,
2014). The small, sonicated liposomes (17 µl) were incubated
with 5 µg of α-synuclein in HKE buffer (25 mM HEPES, pH 7.4,
150 mM KCl, 1 mM EDTA) for 2 h at room temperature (RT;
100 µl total volume). Samples were then loaded onto the bottom
of an Accudenz gradient (40%, 35%, 30%, 0% from bottom to top;
800 µl total; Accurate Chemical and Scientific Corp., Westbury,
NY, USA) and ultracentrifuged at 280,000× g for 3 h at RT
(Figure 2A). After ultracentrifugation, samples were separated
into eight equal fractions, and fluorescence measurements were
made on each fraction using a Nanodrop 3300 in order to
determine the distribution of liposomes. In all experiments, it was
determined that >90% of the liposomes floated up into fractions
1–3 (Figure 2B). The amount of α-synuclein in each fraction was
subsequently determined by Western blotting, as in prior studies
(Figure 2C; Burré et al., 2012; Busch et al., 2014). α-Synuclein
was detected using a pan-synuclein antibody raised against
the N-terminus of human α-synuclein, which recognized both
monomeric and dimeric α-synuclein (1:1000; ab53726; Abcam,
Cambridge, MA, USA). The secondary antibody used was a goat
anti-rabbit HRP conjugated IgG (H + L) (Thermo Scientific,
Waltham, MA, USA). Protein bands were detected using
PierceTM ECL Western blotting substrate (Thermo Scientific,
Waltham, MA, USA). α-Synuclein band intensity was quantified
in each fraction using FIJI 2.0.0 software, and the percentage
of liposome-bound α-synuclein in fractions 1–3 was determined
in n = 3–4 independent experiments for each experimental
condition.
Microinjection, Stimulation and EM
Imaging at Lamprey Synapses
All animal procedures were approved by the Institutional Animal
Care and Use Committee at the Marine Biological Laboratory
in Woods Hole, MA and in accordance with standards set
by the National Institutes of Health. Lampreys (Petromyzon
marinus; 11–13 cm) were anesthetized in MS-222 (0.1 g/L;
Western Chemicals Inc., Ferndale, WA, USA), after which
2–3 cm pieces of spinal cords were microdissected and pinned
in a Sylgard-lined petri dish containing fresh, oxygenated
Lamprey Ringer (100 mM NaCl, 2.1 mM KCl, 1.8 mM
MgCl2, 4 mM glucose, 2 mM HEPES, 0.5 mM L-glutamine,
2.6 mM CaCl2, pH 7.4). CC dimer (50 µM), NC dimer (80
µM), Dynasore (80 µM; Abcam ab120192; Cambridge, MA,
USA) and monomeric α-synuclein (160 µM; rPeptide), all
diluted in lamprey internal solution to the indicated stock
concentrations, were loaded into glass microelectrodes and
subsequently injected into lamprey giant RS axons using small
pulses of nitrogen delivered via a Toohey Spritzer. All reagents
were co-injected with a fluorescent dextran approximating their
molecular weights in order to determine how much reagent
was injected and how far it spread via axonal diffusion. For
experiments with α-synuclein dimers, we co-injected a 40 kDa
fluorescein dextran (Thermo Fisher Scientific, D1845; Waltham,
MA, USA). For Dynasore experiments, we co-injected a 3 kDa
fluorescein dextran (Thermo Fisher Scientific, D3309; Waltham,
MA, USA). For experiments with monomeric α-synuclein, we
co-injected a 10 kDa Alexa Fluorr 488 dextran (Thermo
Fisher Scientific, D22910; Waltham, MA, USA). The spread
of the fluorescent dye, as well as its intensity along the
axon relative to the injection site, were monitored during
the injection in order to estimate the final intra-axonal
concentration of the proteins (see Figure 3B). By the fluorescence
measurements, the α-synuclein and other reagents were diluted
>10–20 times from the stock concentration in typical injection
experiments.
After the injections were complete, the lamprey giant
RS axons were stimulated intracellularly with short current
pulses (30–70 nA; 1 ms) in order to trigger action potentials
(20 Hz, 5 min). Spinal cords were fixed immediately in 3%
glutaraldehyde, 2% paraformaldehyde in 0.1 M Na cacodylate,
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pH 7.4, processed with 2% osmium in 2% potassium ferrocyanide
(EM Sciences, Hatfield, PA, USA), stained en bloc with
2% uranyl acetate and embedded in EMbed 812 resin, as
previously described (Morgan et al., 2004, 2013b; Busch et al.,
2014). In order to evaluate the tissue quality and to identify
the injected axon, histological staining was performed on 1
µm sections stained with a 1% toluidine blue, 1% sodium
borate solution for 1–2 min (see Figure 3A, for example).
For electron microscopy, spinal cords were thin sectioned
at 70 nm onto formvar coated copper slot grids, post
stained with 2% uranyl acetate and 0.4% lead citrate, and
subsequently imaged using a JEOL JEM 200CX transmission
electron microscope at 37,000× or 59,000× magnification. For
each experimental condition, all synapses containing a clearly
defined presynaptic active zone were imaged in series. Images
that contained the center of the active zone were selected
for further morphometric analyses (n = 10–26 synapses per
condition).
As described previously, morphometric analyses were
performed on all synaptic membranes within a 1 µm radius
of the presynaptic active zone using FIJI 2.0.0 by a researcher
blinded to the experimental conditions (Morgan et al., 2004,
2013b; Busch et al., 2014). These analyses included the number of
SVs, size of plasma membrane (PM) evaginations, number and
size of membranous ‘‘cisternae’’, and number and stage of CCPs
and CCVs per synapse, as determined from single thin sections.
SVs were defined as small, clear round vesicles <100 nm in
diameter. PM evaginations were measured by drawing a straight,
1µm line from the edge of the active zone to the nearest point on
the axolemma in either direction, measuring the curved distance
between these points, then recording the average from each
synapse. ‘‘Cisternae’’ were defined as larger, atypical vesicles
>100 nm in diameter. CCP/Vs were determined by the presence
of an electron dense coat around the vesicle membrane. In
addition, a total membrane analysis was performed on each
synapse in order to determine how the synaptic membranes
were redistributed after acute perturbations. Here, the SV
and CCP/V membrane areas were determined by multiplying
the surface area of a sphere (4pir2) by the number of SVs
or CCP/Vs at each synapse, respectively, where r = d/2 and
d = the average diameter of 200 SVs measured from each
experimental condition. Cisternae and PM measurements were
obtained by multiplying the summed cisternae perimeters and
length of PM evaginations by the section thickness (70 nm)
in order to obtain the total amount of membrane area. For
the analysis on the necks of CCPs (Figure 6), the neck width
was measured at its narrowest point, and the neck length
was measured from the PM to the beginning of the clathrin
coat. All graphed data represent the mean ± SEM per section
per synapse. Graphs were generated using Origin Pro 7.0
(OriginLab, Northampton, MA, USA). As previously described
(Busch et al., 2014), 3D reconstructions of five serial electron
micrographs were generated using Reconstruct software version
1.1.0.0 (Fiala, 2005). PM and cisternae were rendered as trace
slabs; SVs and CCP/Vs were rendered as 50 nm and 90 nm
spheres, respectively; active zone was rendered as a Boissonnat
surface.
RESULTS
Stable, Recombinant α-Synuclein Dimers
Human α-synuclein (140 a.a) comprises an N-terminal domain
that mediates membrane binding and folds into an amphipathic
helix upon interactionwith small, highly curved vesicles; a central
core non-amyloid component (NAC) domain that mediates
self-association; and a less structured C-terminus containing
acidic residues and prolines (Figure 1A). The goal of this
study was to determine how α-synuclein dimers affect SV
trafficking. We therefore synthesized two stable recombinant
α-synuclein dimers, as described in the ‘‘Materials and Methods’’
section and a prior study (Pivato et al., 2012). CC dimer was
generated by covalent linkage of two α-synuclein molecules
at their C-termini (Figure 1B). NC dimer was generated by
expression of two α-synuclein molecules in tandem in a single
polypeptide, thereby bringing together the N- terminus of one
α-synuclein with the C-terminus of the other (Figure 1B).
While the exact conformations of endogenous α-synuclein
FIGURE 1 | Stable recombinant α-synuclein dimers. (A) Domain diagram of
monomeric human α-synuclein. (B) Diagrams of the α-synuclein dimers used
in this study. CC dimer brings together the C-termini of two α-synuclein
molecules via disulfide bonds. NC dimer was generated by engineering two
copies of α-synuclein in tandem to generate a single polypeptide.
(C) Coomassie stained 12% SDS-PAGE gel showing α-synuclein monomer
and dimers and their respective molecular weights.
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dimers are unknown, formation of parallel and anti-parallel
multimers was implied through the use of bimolecular
fluorescence complementation assays (Wang et al., 2014). Thus,
the recombinant α-synuclein dimers, which likely adopt parallel
and anti-parallel conformations, allowed us to test the efficacy
of each form. The α-synuclein dimers were stable in SDS-PAGE
under non-reducing conditions (Figure 1C). While monomeric
α-synuclein ran at ∼14 kDa by SDS-PAGE, CC and NC dimers
ran higher around∼28 kDa, as expected for these larger proteins
(Figure 1C).
α-Synuclein Dimers Bind to Small
Liposomes Containing Acidic
Phospholipids
A prior study showed that the α-synuclein CC and NC dimers
exhibited many biochemical properties similar to monomeric
α-synuclein, including folding, fibrillation and aggregation, albeit
with slightly altered dynamics (Pivato et al., 2012). Here, we
additionally characterized the lipid binding capabilities of the
α-synuclein dimers. Monomeric α-synuclein binds in vitro to
anionic phospholipids when presented in small, highly-curved
liposomes (30–50 nm diameter; Davidson et al., 1998; Burré
et al., 2010, 2012, 2015; Busch et al., 2014). Lipid binding
induces the N-terminal domain of α-synuclein to adopt an
alpha helical conformation, which likely contributes to its ability
to bind to SVs in vivo (Maroteaux et al., 1988; Davidson
et al., 1998; Fortin et al., 2005). We previously showed that
α-synuclein point mutations that reduced alpha helical content
and liposome binding also greatly reduced the synuclein-induced
vesicle trafficking defects at lamprey RS synapses, implicating
membrane binding as a significant contributor to the observed
synaptic defects (Busch et al., 2014). These findings are consistent
with studies at mammalian synapses (Nemani et al., 2010; Xu
et al., 2016; Eguchi et al., 2017).
To estimate whether α-synuclein dimers might also induce
vesicle trafficking defects, we therefore tested the lipid binding
capacity of the α-synuclein dimers using a well-established
liposome binding assay (Figure 2; Burré et al., 2010, 2012;
Busch et al., 2014). Briefly, monomeric or dimeric α-synuclein
was incubated with small, sonicated liposomes (∼30 nm)
and then loaded onto the bottom of an Accudenz gradient.
After ultracentrifugation and separation into eight fractions
(Figure 2A), fluorometer measurements indicated that 90%–95%
of the liposomes floated into the top three fractions (Figure 2B).
Figure 2B shows representative fluorometer data obtained from
liposomes made with PC or a 1:1 mixture of PC and PA.
Consequently, any liposome-bound α-synuclein, as detected by
Western blotting, will also be present in fractions 1–3, while
unbound α-synuclein will remain in fractions 4–8 (Figure 2A).
As previously reported (Burré et al., 2012; Busch et al.,
2014), monomeric α-synuclein exhibited very little binding
to PC liposomes, but bound robustly to PC/PA liposomes
(Figures 2C,D;Monomeric α-synuclein—PC: 12.3± 7.4%, n = 4;
PC/PA: 96.9 ± 1.6%, n = 3; Student’s t-test, p = 0.0002).
Similarly, CC and NC dimers exhibited stronger binding to
PC/PA liposomes than to PC only liposomes, as shown by
FIGURE 2 | α-Synuclein dimers bind to phosphatidic acid (PA)-containing
liposomes. (A) Diagram of the liposome binding assay. After incubation of
α-synuclein with liposomes, ultracentrifugation in an Accudenz gradient results
in flotation of liposomes along with any bound protein to top fractions.
(B) Fluorometer measurements showing the distribution of liposomes after
ultracentrifugation. Note that >90% of liposomes are found in fractions 1–3.
(C) Western blots showing the amount of α-synuclein that is bound to
liposomes (fractions 1–3) or unbound (fractions 4–8). Monomeric α-synuclein
exhibits very little binding to phosphatidylcholine (PC) liposomes, but binds
robustly to 1:1 PC/PA liposomes. CC and NC dimers follow a similar pattern of
binding. (D) Quantification of band intensities from Western blots. Monomeric
and dimeric α-synuclein all exhibit a significant increase in binding to PC/PA
liposomes, compared to PC alone. Bars represent mean ± SEM of the
percentage of total α-synuclein bound, as measured in n = 3–4 independent
experiments. Asterisks indicate statistical significance by Student’s t-test
(p < 0.05). (E) Direct comparison of PC and PC/PA binding by monomeric or
dimeric α-synuclein. Asterisks indicate statistical significant by analysis of
variance (ANOVA; p < 0.05).
a shift of the protein into the top fractions of the column
(Figures 2C,D). Quantification of Western blot band intensities
revealed significantly greater binding of the α-synuclein dimers
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to PC/PA liposomes, compared to liposomes containing only
PC (Figure 2D; CC dimer—PC: 21.2 ± 2.5%, n = 3; PC/PA:
64.4 ± 9.7%, n = 3; Student’s t-test, p = 0.01; NC dimer—PC:
30.0 ± 3.5%, n = 3; PC/PA: 51.1 ± 3.9%, n = 3; Student’s
t-test, p = 0.02). When directly compared, α-synuclein, CC
and NC dimers exhibited no difference in binding to PC
liposomes (ANOVA p > 0.05; Figure 2E). However, CC
and NC dimers did exhibit a 34% and 47% reduction in
binding to PC/PA liposomes, respectively (ANOVA p < 0.05;
Figure 2E). Thus, while α-synuclein dimers preferentially bind
to liposomes containing an anionic phospholipid such as PA,
they also bind with reduced efficacy compared to monomeric
α-synuclein, predicting that they may produce distinct effects on
SV trafficking.
α-Synuclein Dimers Inhibit Synaptic
Vesicle Recycling, Including Effects on the
Clathrin Pathway
Next, we wanted to determine whether and how acute
introduction of α-synuclein dimers affects SV trafficking. We
used as our experimental model lamprey giant RS synapses,
which are large (1–2 µm in diameter) glutamatergic, en passant
synapses that reside along the perimeter of the giant axons
(20–40 µm in diameter) within the ventromedial spinal cord
(Figure 3A). α-Synuclein CC and NC dimers were acutely
delivered via microinjection into the giant RS axons, providing
direct access of the proteins to the presynapses (Figures 3B,C).
Co-injection of a fluorescent dye with a similar molecular
weight allowed us to approximate the concentrations of the
α-synuclein dimers along the axon with respect to the injection
site (Figure 3B). After dimer injections, the axons were
stimulated intracellularly with action potentials (20 Hz, 5 min).
Immediately following the stimulation period, spinal cords were
fixed and processed for electron microscopy for visualization
of RS synapses. The RS synapses consist of large vesicle
clusters (∼100–150 SVs/section; 1000–2000 SVs total) positioned
along the axolemma and centered around an electron dense
active zone (Figures 3C,D). We examined the ultrastructural
effects of CC and NC dimers on synapses located within three
regions of the axon (Figure 3B): (1) 25–225 µm from the
injection site where α-synuclein dimer concentrations were
higher (estimated 5–8µM; see ‘‘Materials andMethods’’ section);
(2) 250–390 µm from the injection site where α-synuclein
dimer concentrations were lower (estimated 0.5–4 µM); and
(3) >400 µm from the injection site where no exogenous
α-synuclein was present (0 µM). This last region allowed us
to assess the normal morphologies of untreated, stimulated
synapses, thereby providing an internal control. The maximal
amount of exogenous α-synuclein injected (5–8 µM) was only
2–3 times greater than the current estimate of endogenous
α-synuclein at synapses, which is 3–6 µM (Westphal and
Chandra, 2013). Thus, the additional α-synuclein introduced
to synapses is commensurate with the two- to three-fold
overexpression levels observed in PD and animal models
(Singleton et al., 2003; Rockenstein et al., 2005; Nemani et al.,
2010; Scott et al., 2010).
FIGURE 3 | Lamprey reticulospinal (RS) synapses and injection strategy.
(A) Cross-section (1 µm thick) of a lamprey spinal cord stained with toluidine
blue. Note the giant RS axons in the ventromedial tract. V—ventral; D—Dorsal.
(B) Diagram of a lamprey spinal cord showing the strategy for axonal
microinjection and stimulation. After microinjection of the α-synuclein dimers,
the synapses within three regions of the axon were evaluated: those treated
with higher concentrations of the protein (5–8 µM), lower concentrations of
the protein (0.5–4 µM), or no protein (0 µM; Controls). These regions were
determined based on diffusion of a co-injected fluorescent dye. (C) Diagram of
an injected RS axon indicating the locations of giant RS synapses along the
axonal perimeter. (D) Electron micrograph of an unstimulated, control RS
synapse showing the large size of the synaptic vesicle (SV) cluster.
Under these stimulation conditions, control RS synapses
exhibited large SV clusters, shallow PM evaginations and only a
few CCPs (Figures 4A,D). Compared to unstimulated synapses
(Figure 3D), stimulated synapses have slightly fewer vesicles,
less compact SV clusters and more CCPs, indicating that vesicle
recycling is occurring. In comparison, at synapses treated with
low concentrations of α-synuclein CC dimer (α-Syn-CC-L),
the SV clusters were even smaller; PM evaginations were
more extended; and, large vesicles (>100 nm diameter) with
irregular shapes, which we call ‘‘cisternae,’’ were more abundant
(Figures 4B,E). In addition, there were greater numbers of
clathrin-coated pits (CCPs), including complex tubules ending
in clathrin coats, budding from the PM (Figures 4B,E; see
insets). A loss of SVs combined with an increase in PM and
endocytic intermediates is consistent with an inhibition of SV
endocytosis from the PM. At higher concentrations of CC dimer
(α-Syn-CC-H), a similar phenotype was observed with fewer
SVs, larger PM evaginations and more cisternae and CCPs,
but the effects were even more pronounced (Figures 4C,F).
3D reconstructions of serial sections corroborated the endocytic
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FIGURE 4 | α-Synuclein CC dimer inhibits SV endocytosis. (A–C) Electron micrographs showing a typical control synapse, compared to synapses treated with either
low or high concentrations of α-synuclein CC dimer (α-Syn-CC). L, low concentration; H, high concentration. Synapses treated with CC dimer exhibited SV recycling
defects, as shown by a reduction in SVs, expanded plasma membrane (PM) evaginations (dotted lines), and greater numbers of endocytic intermediates including
cisternae (C) and clathrin-coated pits (CCPs) with constricted necks (red circles). Insets show longer, branched tubules ending in clathrin coats. Arrowheads indicate
their connections with the PM. Asterisks mark the complex budding structures shown in the insets. Scale bar in (A) also applies to (B,C). (D–F) 3D reconstructions
reveal the extent of the endocytic defects induced by CC dimer, shown by a loss of SVs (blue), larger PM evaginations (green) and build up of cisternae (magenta),
CCPs (yellow) and CCVs (white). Red slab marks the active zone. (G–K) Electron micrographs show typical CCPs at control (G) and CC dimer-treated synapses
(H–K). Note the abundance of CCPs, including those with complex structures induced by CC dimer. Arrowheads indicate their connections with the PM. Scale bar in
(G) applies to (H–K). (L–Q) Quantification of the SV recycling defects. The reduction in SVs (L) was compensated by increased PM evaginations, cisternae and
CCPs and vesicles (M–Q). Data reported indicate the averages per synapse, as measured from single sections. Bars represent mean ± SEM from
n = 26–27 synapses, 2–3 axons. Asterisks indicate statistical significance (p < 0.05) by ANOVA, as compared to controls.
phenotypes observed in single sections and also further
emphasized the build up of CCPs at the PM (Figures 4D–F;
yellow spheres and insets). In contrast, the free CCVs did not
appear to be dramatically affected (Figures 4E,F, white spheres).
A higher magnification view of the synaptic membranes revealed
that control synapses typically exhibited only one or several CCPs
with constricted necks (Figure 4G). In comparison, synapses
treated with CC dimer often exhibited rows of constricted
CCPs with normal appearance emanating directly from the
PM (Figure 4H, arrowheads), as well as atypical complex buds
and tubules ending in multiple clathrin coats (Figures 4I–K,
arrowheads), suggesting a defect in vesicle fission during SV
endocytosis.
Morphometric analyses further corroborated that α-synuclein
CC dimer induced endocytic defects at synapses. The number
of SVs was significantly reduced at synapses treated with CC
dimer, compared to controls, especially at higher concentrations
(Figure 4L; Control: 112.4 ± 11.7 SVs, n = 26 synapses,
3 axons; α-Syn-CC-L: 88.5 ± 7.8 SVs, n = 27 synapses,
2 axons; α-Syn-CC-H: 45 ± 5.3 SVs, n = 25 synapses, 2 axons;
ANOVA p = 3.3 × 10−6; Tukey’s post hoc). The mean diameter
of the remaining SVs was not significantly altered (Control:
52.2 ± 0.7 nm, n = 200 SVs; α-Syn-CC-L: 50.9 ± 0.6 nm,
n = 200 SVs; α-Syn-CC-H: 53.7 ± 0.9 nm, n = 200 SVs;
ANOVA p = 0.03; Tukey’s post hoc). PM evaginations became
progressively larger with increased concentrations of CC dimer
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(Figure 4M; Control: 2.0 ± 0.2 µm, n = 26 synapses, 3 axons; α-
Syn-CC-L: 2.6± 0.2 µm, n = 27 synapses, 2 axons; α-Syn-CC-H:
3.7± 0.3 µm, n = 25 synapses, 2 axons; ANOVA p = 9.7× 10−7,
Tukey’s post hoc). Both the number and size of cisternae
were also significantly increased after treatment with CC dimer
(Figures 4N,O) (# Cisternae—Control: 2.9 ± 0.4 cisternae,
n = 26 synapses, 3 axons; α-Syn-CC-L: 5.7 ± 1.0 cisternae,
n = 27 synapses, 2 axons; α-Syn-CC-H: 7.5 ± 0.9 cisternae,
n = 25 synapses, 2 axons; ANOVA p = 6.5 × 10−4, Tukey’s post
hoc; Size Cisternae—Control: 0.37 ± 0.01 µm, n = 76 cisternae,
26 synapses; α-Syn-CC-L: 0.38 ± 0.01 µm, n = 153 cisternae,
27 synapses; α-Syn-CC-H: 0.49 ± 0.03 µm, n = 186 cisternae,
25 synapses; ANOVA p = 2.3 × 10−4, Tukey’s post hoc).
In addition, the total number of CCPs and CCVs combined
(i.e., ‘‘clathrin coats’’) was also significantly increased (Figure 4P;
Control: 3.4 ± 0.3 coats, n = 26 synapses, 3 axons; α-Syn-
CC-L: 7.1 ± 0.8 coats, n = 27 synapses, 2 axons; α-Syn-
CC-H: 7.1 ± 0.8 coats, n = 25 synapses, 2 axons; ANOVA
p = 0, Tukey’s post hoc). We also performed a comprehensive
analysis of the total membrane distribution at synapses. This
analysis revealed that the loss of SV membrane area was
compensated by greater membrane area in the PM, cisternae
and clathrin coat compartments (Figure 4Q; Control: 1.4 ± 0.1
µm2, n = 26 synapses, 3 axons; α-Syn-CC-L: 1.3 ± 0.08 µm2,
n = 27 synapses, 2 axons; α-Syn-CC-H: 1.3 ± 0.08 µm2,
n = 25 synapses, 2 axons; ANOVA p = 0.84, Tukey’s post hoc).
Taken together, these data indicate that α-synuclein CC dimer
induced a dose-dependent inhibition of SV endocytosis from the
FIGURE 5 | α-Synuclein NC dimer also inhibits SV endocytosis. (A–C) Electron micrographs showing a control synapse and those treated with either low or high
concentrations of α-synuclein NC dimer (α-Syn-NC). L, low concentration; H, high concentration. NC dimer produced a phenotype that nearly identical to that
caused by CC dimer (see Figure 4). After treatment with NC dimer, synapses exhibited SV recycling defects, as shown by a reduction in SVs, expanded PM
evaginations (dotted lines) and greater numbers of cisternae (C) and CCPs with constricted necks (red circles). Scale bar in (A) applies to (B,C). (D–F) 3D
reconstructions show the SV recycling defects induced by NC dimer, as demonstrated by a loss of SVs (blue), larger PM evaginations (green) and build up of
cisternae (magenta), CCPs (yellow) and CCVs (white). Red slab marks the active zone. (G–K) Electron micrographs show typical CCPs at control (G) and NC
dimer-treated synapses (H–K). Note the abundance of CCPs, including those with complex structures induced by NC dimer. Arrowheads indicate their connections
with the PM. (L–Q) Quantification of the SV recycling defects produced by NC dimer. The reduction in SVs (L) was compensated by increased PM evaginations,
cisternae and CCPs and vesicles (M–Q). Data reported indicate the averages per synapse, as measured from single sections. Bars represent mean ± SEM from
n = 10–24 synapses, 1–2 axons. Asterisks indicate statistical significance (p < 0.05) by ANOVA, as compared to the controls.
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FIGURE 6 | α-Synuclein dimers inhibit vesicle fission and induce membrane tubulation during clathrin-mediated SV endocytosis. (A) Model of clathrin-mediated SV
endocytosis, including several molecular players. Graphics generated by Jack Cook (Woods Hole Oceanographic Institution) using Cinema 4D. (B–E) Quantitative
analysis of each morphologically distinct stage of CCP and CCV formation. Refer to (A) for individual stages. This analysis revealed that CC and NC dimer inhibited
vesicle fission, as indicated by a selective increase in stage 3 CCPs. Similarly, and as expected, Dynasore inhibited vesicle fission. In contrast, monomeric α-synuclein
inhibited a different stage of clathrin-mediated endocytosis, during clathrin uncoating (stage 4). Data reported indicate the averages per synapse, as measured from
single sections. Bars represent mean ± SEM from n = 10–26 synapses, 1–3 axons. Asterisks indicate statistical significance (p < 0.05) by ANOVA, as compared to
the controls. (F) Electron micrographs showing the observed morphologies of CCPs under the various experimental conditions. (Top) CC and NC dimers induced
individual CCPs with longer necks (asterisks), compared to control, Dynasore, or monomer-treated synapses. (Bottom) CC and NC dimers also induced more
complex budding structures extending from branched membrane tubules. Arrowheads indicate their connections with the PM. (G) Serial images (i, ii) and a 3D
reconstruction (i + ii) showing a complex tubule extending from the PM ending in multiple CCPs. Arrowheads indicate the connections with the PM. (H–K) The
α-synuclein dimers significantly increased the number of single and complex buds. In addition, neck length on CCPs, but not neck width, was increased with the
α-synuclein dimers. Data reported indicate the averages per synapse, as measured from single sections. Bars represent mean ± SEM from n = 6–28 synapses,
1–3 axons. Asterisks indicate statistical significance (p < 0.05) by ANOVA, as compared to the controls.
PM, including effects on the clathrin pathway. The atypical CCPs
observed further suggested that CC dimer impairs vesicle fission
during clathrin-mediated endocytosis.
Similarly, we also examined the synaptic effects produced
by NC dimer. Acute introduction of α-synuclein NC dimer
produced nearly identical effects on SV endocytosis, but the
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effects were slightly more pronounced even at the lower
concentrations. Both low and high concentrations of NC dimer
impaired synaptic morphology, resulting in progressively smaller
SV clusters (Figures 5A–F,L; Control: 133.1 ± 15.8 SVs,
n = 10 synapses, 2 axons; α-Syn-NC-L: 63.5 ± 8.3 SVs,
n = 24 synapses, 1 axon; α-Syn-NC-H: 33.2 ± 5.2 SVs,
n = 23 synapses, 1 axon; ANOVA p = 9.96 × 10−9; Tukey’s
post hoc). At the higher concentrations of NC dimer, the
mean SV diameter was slightly larger than at control synapses
(Control: 54.0 ± 0.6 nm, n = 200 SVs, 10 synapses; α-Syn-
NC-L: 55.7 ± 0.6 nm, n = 200 SVs, 10 synapses; α-Syn-
NC-H: 56.5 ± 0.8 nm, n = 200 SVs, 10 synapses; ANOVA
p = 0.02; Tukey’s post hoc). PM evaginations were significantly
larger after treatment with NC dimer (Figures 5A–F,M;
Control: 1.9 ± 0.2 µm, n = 10 synapses, 2 axons; α-Syn-
NC-L: 4.0 ± 0.3 µm, n = 24 synapses, 1 axon; α-Syn-NC-H:
4.0 ± 0.4 µm, n = 23 synapses, 1 axon; ANOVA p = 0.00011,
Tukey’s post hoc). As with CC dimer, the number and size
of cisternae were also significantly increased (Figures 5N,O; #
Cisternae—Control: 3.0± 0.6 cisternae, n = 10 synapses, 2 axons;
α-Syn-NC-L: 9.6 ± 0.8 cisternae, n = 24 synapses, 1 axon;
α-Syn-CC-H: 8.3 ± 1.3 cisternae, n = 23 synapses, 1 axon;
ANOVA p = 0.0026, Tukey’s post hoc; Size Cisternae—Control:
0.39 ± 0.01 µm, n = 30 cisternae, 10 synapses; α-Syn-NC-L:
0.42 ± 0.01 µm, n = 219 cisternae, 24 synapses; α-Syn-NC-
H: 0.49 ± 0.02 µm, n = 188 cisternae, 23 synapses; ANOVA
p = 0.0039, Tukey’s post hoc). As with CC dimer, NC dimer also
induced aberrant CCP budding from the PM (Figures 5E–K),
resulting in greater numbers of CCPs with normal appearance
(Figure 5H) as well as atypical, complex budding structures
extending from the PM (Figures 5I–K, arrowheads). The
total number of clathrin coats was significantly greater than
at control synapses (Figure 5P; Control: 1.8 ± 0.3 coats,
n = 10 synapses, 2 axons; α-Syn-NC-L: 8.2 ± 0.9 coats,
n = 24 synapses, 1 axon; α-Syn-NC-H: 7.2 ± 0.9 coats,
n = 23 synapses, 1 axon; ANOVA p = 2.81 × 10−4, Tukey’s
post hoc). Total membrane analysis revealed that the loss of
SV membrane area induced by NC dimer was compensated by
greater membrane area in the PM, cisternae, and CCPs and
CCVs (Figure 5Q; Control: 1.57 ± 0.17 µm2, n = 10 synapses,
1 axon; α-Syn-NC-L: 1.44 ± 0.09 µm2, n = 23 synapses,
1 axon; α-Syn-NC-H: 1.25 ± 0.12 µm2, n = 24 synapses,
1 axon; ANOVA p = 0.21, Tukey’s post hoc). Thus, as
with CC dimer, NC dimer also impaired clathrin-mediated
SV endocytosis with apparent effects on the vesicle fission
process.
α-Synuclein Dimers Inhibit Vesicle Fission
during Clathrin-Mediated Endocytosis
Clathrin-mediated SV endocytosis proceeds through several
morphologically distinct stages (Figure 6A; Brodin et al., 2000;
Morgan et al., 2002, 2013a; Saheki and De Camilli, 2012).
As in our prior studies, we have defined them according to
the stages of clathrin coat formation (Morgan et al., 2004,
2013b; Bourne et al., 2006; Busch et al., 2014). Initiation
of clathrin coat formation begins when the adaptor proteins
AP180 and AP2 recruit clathrin triskelions to the PM (Stage 1).
Following maturation of the clathrin coat (Stage 2), the
GTPase dynamin is recruited to the neck of the CCP, where
its GTPase activity leads to constriction and vesicle fission
(Stage 3). Once separated from the PM, the free CCV is
uncoated by the ATP activity of the chaperone protein Hsc70
(Stage 4). The aberrant vesicle budding observed with CC
and NC dimers suggested that they may be affecting the
process of vesicle budding at the fission step. To test this,
we examined the number of CCPs (Stage 1–3) and CCVs
(Stage 4) at synapses after treatment with the α-synuclein
dimers. Both CC and NC dimers selectively and significantly
increased the number of Stage 3 CCPs with constricted necks,
indicating an impairment in vesicle fission (Figures 6B,C;
CC dimer: Stage 1-Control: 0.1 ± 0.1 CCPs; α-Syn-CC-H:
0 ± 0 CCPs; Stage 2-Control: 0.3 ± 0.1 CCPs; α-Syn-CC-H:
0.3 ± 0.1 CCPs; Stage 3-Control: 2.2 ± 0.3 CCPs; α-Syn-CC-H:
5.4 ± 0.6 CCPs; Stage 4-Control: 0.9 ± 0.2 CCVs; α-Syn-
CC-H: 1.4 ± 0.3 CCVs; n = 10–26 synapses per condition;
ANOVA p < 0.00005, Tukey’s post hoc; NC dimer: Stage 1-
Control: 0.1 ± 0.1 CCPs; α-Syn-NC-H: 0.1 ± 0.1 CCPs; Stage
2-Control: 0.4 ± 0.2 CCPs; α-Syn-NC-H: 0.5 ± 0.2 CCPs; Stage
3-Control: 1.1 ± 0.4 CCPs; α-Syn-NC-H: 5.3 ± 0.7 CCPs; Stage
4-Control: 0.4 ± 0.3 CCVs; α-Syn-CC-H: 1.4 ± 0.3 CCVs;
n = 10–26 synapses per condition; ANOVA p = 0, Tukey’s
post hoc).
To corroborate that α-synuclein dimers were indeed causing
a bona fide fission defect, we also examined the effects of
Dynasore (80 µM), a potent and selective inhibitor of dynamin
GTPase activity that arrests late stages of budding prior to
vesicle fission, leading to an increase in CCPs with constricted
necks that are still attached to the membrane (Macia et al.,
2006; Newton et al., 2006). We performed these experiments
using the same injection and stimulation conditions as in the
α-synuclein dimer experiments. After diffusion and dilution,
we estimate that the final axonal concentration of Dynasore
was ∼4–8 µM. As with CC and NC dimers, Dynasore also
selectively increased the number of stage 3 CCPs (Figure 6D;
Stage 1-Control: 0.1 ± 0.1 CCPs; Dynasore: 0.1 ± 0.1 CCPs;
Stage 2-Control: 0.4 ± 0.1 CCPs; Dynasore: 0.1 ± 0.1 CCPs;
Stage 3-Control: 2.0 ± 0.2 CCPs; Dynasore: 3.5 ± 0.4 CCPs;
Stage 4-Control: 1.1 ± 0.2 CCVs; Dynasore: 1.5 ± 0.4 CCVs;
n = 23 control synapses, n = 19 Dynasore synapses; ANOVA
p < 0.00005, Tukey’s post hoc). We also examined the effects
of monomeric α-synuclein on each stage of clathrin coat
formation, which we had not done in our prior study (Busch
et al., 2014). Surprisingly, and in contrast to α-synuclein
dimers and Dynasore, monomeric α-synuclein impaired a later
stage of clathrin-mediated endocytosis during the uncoating
step, as shown by a selective increase in stage 4, free CCVs
(Figure 6E; Stage 1-Control: 0.1 ± 0.1 CCPs; Monomeric
α-Syn: 0.2 ± 0.2 CCPs; Stage 2-Control: 0.3 ± 0.1 CCPs;
Monomeric α-Syn: 0.8 ± 0.3 CCPs; Stage 3-Control:
1.4 ± 0.3 CCPs; Monomeric α-Syn: 1.0 ± 0.4 CCPs; Stage
4-Control: 0.6 ± 0.2 CCVs; Monomeric α-Syn: 3.7 ± 1.2 CCVs;
n = 6–14 synapses per condition; ANOVA, p = 1.38 × 10−7,
Tukey’s post hoc). Thus, α-synuclein CC and NC dimers
selectively inhibited the vesicle fission step during clathrin-
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FIGURE 7 | Monomeric and dimeric α-synuclein produce distinct effects on clathrin-mediated SV recycling. (A) Electron micrograph showing a stimulated synapse
treated acutely with excess monomeric α-synuclein, which causes a reduction in SVs and an expansion of the PM (dotted line). Numerous endocytic intermediates
are also observed, including cisternae (C), CCPs (red circles) and free CCVs (blue circles). (B) 3D reconstruction of the same synapse. Note the abundance of CCVs
(white spheres). (C) Inset showing a cluster of CCVs (blue arrowheads) at a synapse treated with monomeric α-synuclein, and only one CCP (red arrowheads).
(D–I) Quantification of the vesicle recycling defects produced by monomeric α-synuclein. Loss of SVs compensated by a buildup of PM and endocytic intermediates
indicates a defect in SV endocytosis. Bars represent mean ± SEM from n = 6–14 synapses. Asterisks indicate statistical significance by Student’s t-test (p < 0.05).
(J–M) 3D reconstructions comparing the distribution of CCPs and CCVs at synapses treated with monomeric or dimeric α-synuclein. While monomeric α-synuclein
induced a buildup of free CCVs (white spheres) throughout the synaptic area, CCPs (yellow spheres) at the PM predominated after treatment with dimeric
α-synuclein. (N–P) Insets showing the different effects on clathrin-mediated endocytosis. Monomeric α-synuclein impairs clathrin uncoating, as indicated by the
buildup of free CCVs (blue arrowheads; inset), and dimeric α-synuclein impairs an earlier stage of endocytosis during the fission step, as indicated by the buildup of
CCPs (red arrowheads; insets). Scale bar in (N) applies to (O,P).
mediated SV endocytosis, while monomeric α-synuclein
appeared to inhibit clathrin uncoating.
In order to better understand the fission defects, we further
examined themorphologies of the CCPs observed in the presence
of α-synuclein dimers. Free CCVs were excluded from these
analyses. At stimulated control synapses, the vast majority
of CCPs were single buds with short, constricted necks, and
only a very small number of complex buds with multiple
clathrin coats were observed (Figure 6F). However, in the
presence of CC and NC dimers, individual CCPs often exhibited
longer necks (Figure 6F, top, asterisks). Furthermore, with
the α-synuclein dimers, there were larger numbers of complex
buds comprising extended membrane tubules ending in multiple
clathrin coats (Figure 6F, bottom). These complex budding
structures typically emanated directly from the PM (Figure 6F,
bottom, arrowheads). A clear example of this can be seen in
Figure 6G, where a long, narrow tubule can be traced through
two adjacent sections, showing its connection with the PM and
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a large number of budding CCPs attached (Figure 6G). The
individual CCPs induced by α-synuclein dimers also appeared
to be morphologically distinct from those observed in the
presence of Dynasore or monomeric α-synuclein, which more
closely resembled controls (Figure 6F, top). Complex buds and
tubules were rarely if ever seen with Dynasore or monomeric α-
synuclein treatment under these conditions (Figure 6F, bottom).
Quantitatively, there were significantly more single and complex
buds at synapses treated with CC and NC dimers, compared
to the other experimental conditions (Figures 6H,I; Single
buds—Control: 2.2 ± 0.2 CCPs; CC dimer: 4.8 ± 0.5 CCPs;
NC dimer: 4.8 ± 0.5 CCPs; Dynasore: 3.4 ± 0.4 CCPs;
Monomeric α-Syn; 2.1 ± 0.3 CCPs; p = 1.46 × 10−10; Tukey’s
post hoc; Complex buds—Control: 0.1 ± 0.1 CCPs; CC dimer:
0.8 ± 0.3 CCPs; NC dimer: 1.0 ± 0.4 CCPs; Dynasore:
0.3 ± 0.2 CCPs; Monomeric α-Syn: 0 ± 0 CCPs; ANOVA
p < 0.001; Tukey’s post hoc). When we further examined the
necks of individual CCPs, we found no difference in the neck
width at synapses treated with α-synuclein dimers, Dynasore,
or monomeric α-synuclein, compared to controls (Figure 6J;
Control: 31.5 ± 1.1 nm, n = 39 CCPs, 28 synapses; α-
Syn CC: 28.9 ± 1.2 nm, n = 34 CCPs, 10 synapses; α-Syn
NC: 35.4 ± 1.3 nm, n = 25 CCPs, 12 synapses; Dynasore:
33.3 ± 1.8 nm, n = 26 CCPs, 10 synapses; Monomeric
α-Syn: 32.0 ± 1.6 nm, n = 16 CCPs, 6 synapses; ANOVA
p = 0.01, Tukey’s post hoc). However, both CC and NC dimers
significantly increased the neck length on CCPs, compared
to all other conditions (Figure 6K; Control: 32.1 ± 1.5 nm,
n = 39 CCPs, 28 synapses; α-Syn CC: 52.0± 2.7 nm, n = 34 CCPs,
10 synapses; α-Syn NC: 58.7 ± 3.6 nm, n = 25 CCPs,
12 synapses; Dynasore: 28.6± 1.8 nm, n = 26 CCPs, 10 synapses;
Monomeric α-Syn: 27.3 ± 1.6 nm, n = 16 CCPs, 6 synapses;
ANOVA p = 0; Tukey’s post hoc). The greater numbers of
elaborated complex buds connected by membrane tubules, as
well as CCPs with longer extended necks, provides further
indication that α-synuclein dimers inhibit vesicle fission during
clathrin-mediated SV recycling.
Monomeric and Dimeric α-Synuclein
Induce Distinct Effects on
Clathrin-Mediated Endocytosis
The analyses above suggested that monomeric and dimeric
α-synuclein produced different effects on clathrin-mediated
SV recycling, such that the dimeric α-synuclein inhibited an
earlier step during vesicle fission while monomeric α-synuclein
inhibited a later step during clathrin uncoating. To corroborate
this, we further examined the endocytic phenotype produced by
monomeric α-synuclein and directly compared it against that
produced by dimers. Notably, in the presence of monomeric
α-synuclein, free CCVs were abundant (Figure 7A, blue
circles), whereas the budding CCPs were sparse (Figure 7A,
red circles). This can be seen clearly in Figure 7C where
a single CCP (red arrowhead) is surrounded by a cluster
of CCVs (blue arrowheads). Clusters of CCVs are highly
unusual and are typically due to clathrin uncoating defects, for
example after perturbations of the clathrin uncoating ATPase,
Hsc70 (Morgan et al., 2001). As reported in our previous
study (Busch et al., 2014), monomeric α-synuclein inhibited
SV recycling, as indicated by a loss of SVs, which was
compensated by an expansion of PM and increased numbers of
endocytic intermediates, including cisternae and total clathrin
coats (Figures 7D–I; SVs: Control: 127.6 ± 12.1 SVs; α-Syn:
34.3 ± 5.0 SVs, Student’s t-test p = 0.00012; PM: Control:
1.8 ± 0.1 µm; α-Syn: 2.9 ± 0.5 µm, Student’s t-test p = 0.005;
# Cist: Control: 2.9 ± 0.5 cisternae; α-Syn: 11.8 ± 3.3 cisternae,
Student’s t-test p = 0.00082; Cist Size: Control: 0.40 ± 0.02
µm; α-Syn: 0.63 ± 0.06 µm, Student’s t-test p = 0.006;
Clathrin coats: Control: 2.4 ± 0.4 coats; α-Syn: 5.7 ± 1.4 coats,
Student’s t-test p = 0.005; Total membrane: Control: 1.47 ± 0.13
µm2, α-Syn: 1.14 ± 0.21 µm2, Student’s t-test p = 0.18;
n = 14 Control synapses, n = 6 α-Syn synapses). While
stimulated control, dimer- and Dynasore-treated synapses
normally exhibited ∼1 CCV per section (Figures 6B–D, Stage
4), in contrast, after treatment with monomeric α-synuclein,
the free CCVs were most prevalent (Figure 6E, Stage 4;
Figures 7A,C).
A direct comparison of the clathrin coat defects produced by
monomeric and dimeric α-synuclein further demonstrated
the differences in their phenotypes. We generated 3D
reconstructions of synapses where the distributions of CCPs
and CCVs are shown in the absence of the other synaptic
organelles. These reconstructions clearly revealed that, in
comparison to control synapses, monomeric α-synuclein
caused an atypical build up of free CCVs that were dispersed
throughout the synaptic area (Figures 7J,K, white spheres).
Conversely, CC and NC dimer caused a buildup of CCPs at
the PM (Figures 7L,M, yellow spheres), and very few CCVs
were observed. High magnification electron micrographs clearly
revealed the differences in the clathrin-coated structures.
Monomeric α-synuclein induced atypical clusters of free CCVs
that were separated from the PM (Figure 7N, blue arrowheads).
α-Synuclein dimers induced CCPs with constricted necks that
were still connected to the PM (Figures 7O,P, red arrowheads).
These data provide evidence that monomeric and dimeric
α-synuclein affect clathrin-mediated SV recycling at different
stages during vesicle endocytosis.
DISCUSSION
This is the first demonstration that acutely introducing excess
levels of α-synuclein dimers to synapses impairs vesicle
endocytosis (Figures 4–7). As such, under these conditions, we
would consider the dimers to be in the class of ‘‘small toxic
oligomers’’. Two variants of α-synuclein dimers (CC and NC
dimers) produced very similar effects at synapses, resulting in
a loss of SVs and increased PM area, as well as increased
numbers of atypical membrane cisternae and CCPs. Similarly,
acute introduction of monomeric α-synuclein has been shown to
impair SV endocytosis at both lamprey andmammalian synapses
(Figure 7; Busch et al., 2014; Xu et al., 2016; Eguchi et al., 2017).
At lamprey synapses, both monomeric and dimeric α-synuclein
lead to a rather robust inhibition of SV endocytosis, resulting
in a 60%–80% loss of the SV pool (Figures 4–7; Busch et al.,
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2014). Notably, this phenotype is markedly more severe than is
observed after acute perturbations of other regulators of clathrin-
mediated endocytosis, such as actin or Hsc70 (Morgan et al.,
2004, 2013b; Bourne et al., 2006). Overexpression of α-synuclein
in mammalian neurons appears to impair SV trafficking by
preferentially affecting vesicle recycling and/or replenishment
(Nemani et al., 2010; Scott et al., 2010), though direct effects on
exocytosis should continue to be explored (Bendor et al., 2013;
Lautenschläger et al., 2017; Logan et al., 2017). We have not
yet tested whether acute introduction of excess α-synuclein to
lamprey RS synapses directly affects exocytosis, though this is
of interest for future studies. Nevertheless, given the measurable
effects on clathrin-mediated SV recycling, the current study
contributes to a growing body of evidence indicating that
increasing levels of α-synuclein at synapses impairs the process
of SV recycling.
α-Synuclein dimers inhibited vesicle fission during clathrin-
mediated SV endocytosis. This was demonstrated by a selective
increase in the numbers of CCPs with constricted necks
emanating from the PM, either as individual buds or at the
ends of branched membrane tubules (Figure 6). A priori, one
would surmise that the vesicle fission defect is due to an
impairment of dynamin GTPase function. However, under the
same experimental conditions Dynasore, a drug that inhibits
dynamin GTPase activity, produced measurably different effects
from the α-synuclein dimers. First, the build up of CCPs was
slightly greater with α-synuclein dimers, compared to Dynasore
treatment (Figure 6). Second, the α-synuclein dimers increased
the neck length on CCPs, whereas Dynasore did not. Finally,
unlike Dynasore, the α-synuclein dimers increased the numbers
of complex buds emanating from PM tubules. Thus, α-synuclein
dimers additionally appeared to induce membrane tubulation as
part of the fission defect, whereas this does not seem to be the
case with Dynasore. In vitro studies have reported membrane
tubulation activity for α-, β- and γ-synuclein (Westphal and
Chandra, 2013), and our data would suggest that this is due
at least in part by formation of stable dimers on the liposome
membranes. Consistent with our findings, in hippocampal
neurons and epithelial cells, Dynasore increased the number of
late stage CCPs with constricted necks and normal appearance,
but conspicuously did not induce long membrane tubules with
clathrin coats at their ends (Macia et al., 2006; Newton et al.,
2006). Taken together, our data suggest that dimeric α-synuclein
produces a vesicle fission defect that is unique and is not simply
caused by an inhibition of dynamin GTPase activity. Further
studies are needed to determine whether α-synuclein dimers have
any other direct or indirect impacts on dynamin function.
Another intriguing finding from this study is that α-synuclein
dimers and monomers caused different effects on clathrin-
mediated SV endocytosis. We previously reported that acute
introduction of monomeric human α-synuclein, or PD-linked
point mutant A53T, caused a two to three fold increase in
the total numbers of CCPs and CCVs combined at lamprey
synapses (Busch et al., 2014). In this study, we further assessed
the effects on each morphologically distinct stage of CCP and
vesicle formation (Figure 6). Compared to the α-synuclein
dimers, which inhibited vesicle fission, monomeric α-synuclein
preferentially impaired a later stage of clathrin-mediated SV
endocytosis during clathrin uncoating, as shown by an increase
in the numbers of free CCVs (Figures 6, 7). In a parallel
study, we have determined that the clathrin uncoating defect
produced by monomeric α-synuclein is caused by a lack
of Hsc70 recruitment to stimulated lamprey synapses; when
exogenous Hsc70 is added back to synapses the vesicle trafficking
defects are nearly eliminated (Banks et al., 2017). Although
we do not yet know the precise molecular mechanism by
which α-synuclein dimers impair vesicle fission, the differences
between the clathrin coat phenotypes produced by monomeric
and dimeric α-synuclein are suggestive of distinct molecular
targets.
Metastable α-synuclein multimers have been observed at
mammalian synapses under physiological conditions, and they
attenuate vesicle release and vesicle recycling (Wang et al.,
2014). Immobile microaggregates and SV bound α-synuclein,
at least some of which must be multimeric, have also been
demonstrated at synapses in a PD mouse model (Spinelli et al.,
2014). Thus it is of increasing importance to understand the
effects of eachmolecular species of α-synuclein, their distribution
at synapses, and their functions if we are to understand the
normal and pathophysiological roles of α-synuclein. Though
it is clear that the recombinant dimers are stable and do not
form higher molecular weight oligomers in vitro according
to NMR spectra (Pivato et al., 2012), we do not yet know
whether the α-synuclein dimers further multimerize once
introduced to the synapse in vivo, nor to what extent they
partition onto synaptic membranes or remain mobile and
cytosolic. However, the fact that the α-synuclein dimers
produced a phenotype that was distinct from monomeric α-
synuclein, and the fact that one dimer variant (NC) is a single
polypeptide, combined with the similarities between CC and
NC dimer phenotypes, suggests that the recombinant dimers
used in our study do not dissociate into monomers within
the synaptic environment. We acknowledge that, unlike our
stable α-synuclein dimers, α-synucleinmonomers andmultimers
in vivo are likely in a dynamic equilibrium within neurons,
undergoing reversible association and disassociation with each
other and with membranes. Nonetheless, the strategy of utilizing
stable α-synuclein dimers allowed us to further establish effects
of α-synuclein at synapses and to begin detecting phenotypic
differences with monomeric α-synuclein. This same strategy
will therefore be useful for determining the effects of other
molecular species of α-synuclein, including tetramers that have
recently been described as the native form of the protein
(Bartels et al., 2011; Dettmer et al., 2013, 2015a), though this
interpretation remains somewhat controversial (Burré et al.,
2013). Doing so will allow us to determine the cellular effects
of each molecular species of α-synuclein and to probe the
underlying molecular mechanisms, providing novel insights into
the normal functions of α-synuclein and its pathophysiological
effects in disease states. Though PD and other neurodegenerative
diseases result from chronic processes, these types of acute
perturbation studies will continue to be useful at revealing
the direct impacts of excess α-synuclein in the absence of
other compensatory effects, thereby elucidating the cellular and
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molecular machinery to be targeted for possible therapeutic
value.
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